Comprehensive assessment of primary and secondary low bone mass using dual-energy X-ray absorptiometry and cone beam CT-a cross-sectional study

利用双能X射线吸收法和锥形束CT对原发性和继发性低骨量进行综合评估——一项横断面研究

阅读:2

Abstract

OBJECTIVES: The present study examined the potential use of CT panoramic mandibular indices on cone beam CT (CBCT) for the assessment of bone density in patients with primary and secondary causes of low bone mass. STUDY DESIGN: The study enrolled 104 postmenopausal women and 66 patients with endocrine-related low bone mass (diabetes mellitus, acromegaly, Cushing syndrome), who underwent dual-energy X-ray absorptiometry (DXA) and CBCT scanning. The study assessed the correlation between DXA parameters (lumbar spine, femoral neck, total hip T-score, bone mineral density [BMD], and trabecular bone score [TBS]) and CBCT-derived indices (CT mandibular index superior [CTI(S)], CT mandibular index inferior [CTI(I)], and CT mental index [CTMI]). RESULTS: Significant correlations were found between the CBCT indices and both quantitative (BMD, T-score) and qualitative (TBS) measures of bone mass. In postmenopausal women, all 3 CBCT indices showed strong correlations with DXA parameters. In secondary endocrine causes, CTMI and CTI(S) were significantly correlated with TBS scores, and CTMI also showed a significant correlation with lumbar BMD. CONCLUSION: The study concludes that CTI(S), CTI(I), and CTMI are valuable for assessing bone density and quality in patients with low bone mass, both in primary and secondary osteoporosis related to diabetes mellitus, acromegaly, and Cushing syndrome. ADVANCES IN KNOWLEDGE: These findings support the use of CBCT as a useful tool for evaluating bone health in the clinical setting and optimizing dental implant result. It is among the first studies to evaluate bone mass quality and quantity in secondary endocrine causes of low bone mass.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。